Literature DB >> 15533606

Can SSRIs reduce the risk of preeclampsia in pregnant, depressed patients?

Shandara Durkee Dawes1.   

Abstract

Preeclampsia causes substantial morbidity and mortality. A significant part of the etiology of preeclampsia involves endothelial damage and platelet activation and in this way can be conceived as an illness with a pathophysiology similar to coronary artery disease. Depression is an independent risk factor for the progression of cardiovascular disease [Am Heart J 140 (2000) S57] and there is evidence to suggest that it may be a risk factor for preeclampsia as well. SSRIs have been shown to reduce the progression of coronary artery disease, independent of improvement in mood. SSRIs may also reduce risk factors for preeclampsia in addition to treating depression in pregnancy. This is an important area for further research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15533606     DOI: 10.1016/j.mehy.2003.10.038

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia.

Authors:  Julie A Vignato; S Banu Gumusoglu; Heather A Davis; Sabrina M Scroggins; Wendy S Hamilton; Debra S Brandt; Gary L Pierce; Boyd A Knosp; Donna A Santillan; Mark K Santillan
Journal:  Reprod Sci       Date:  2022-08-19       Impact factor: 2.924

2.  Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy.

Authors:  Kimberly A Yonkers
Journal:  Am J Psychiatry       Date:  2009-03       Impact factor: 18.112

Review 3.  The expanded biology of serotonin.

Authors:  Miles Berger; John A Gray; Bryan L Roth
Journal:  Annu Rev Med       Date:  2009       Impact factor: 16.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.